Establishment Labs Holdings (ESTA) has disclosed a new risk, in the Regulation category.
Establishment Labs Holdings faces substantial compliance risks with anti-kickback, fraud, and abuse laws in its dealings with customers and third-party payors. These laws, which aim to prevent unethical practices in healthcare, could significantly impact the company’s marketing and distribution strategies. Non-compliance could lead to severe legal consequences, including criminal sanctions, civil penalties, and reputational damage, potentially undermining profits and future earnings. The company’s efforts to adhere to these regulations are likely to incur substantial costs, further affecting their financial position.
Overall, Wall Street has a Strong Buy consensus rating on ESTA stock based on 5 Buys.
To learn more about Establishment Labs Holdings’ risk factors, click here.
